http://dspace.bsu.edu.ru/handle/123456789/46311| Title: | Combined use of arginase II inhibitors and tadalafil for the correction of monocrotaline pulmonary hypertension |
| Authors: | Koklin, I. S. Danilenko, L. M. |
| Keywords: | medicine pharmacology monocrotaline pulmonary hypertension arginase II inhibitors tadalafil |
| Issue Date: | 2019 |
| Citation: | Koklin, I.S. Combined use of arginase II inhibitors and tadalafil for the correction of monocrotaline pulmonary hypertension / I.S. Koklin, L.M. Danilenko // Research Results in Pharmacology. - 2019. - Vol. 5, № 3.- P. 79-85. - Doi: 10.3897/rrpharmacology.5.39522. - Refer.: p. 84. |
| Abstract: | The concept of the regulatory role of endothelium in the pathogenesis of pulmonary hypertension (PH) is fundamental. To study the protective effects of the selective arginase II inhibitors L207-0525 and L327-0346 in combination with tadalafil in a monocrotaline model of pulmonary hypertension in rats |
| URI: | http://dspace.bsu.edu.ru/handle/123456789/46311 |
| Appears in Collections: | Vol. 5, № 3 |
| File | Description | Size | Format | |
|---|---|---|---|---|
| Koklin_Combined.pdf | 1.47 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.